Literature DB >> 35111629

Unenhanced computed tomography for non-invasive diagnosis of hepatic steatosis with low tube potential protocol.

Dong Kyun Kim1, Joon-Il Choi1,2, Yunjung Choi1, Seo Yeon Youn1, Hokun Kim1.   

Abstract

BACKGROUND: Lowering kVp affects the image contrast and computed tomography (CT) attenuation values of low kVp CT is different from those of conventional 120-kVp scans. The purpose of this study is to determine the diagnostic performance and to establish the reference range of low-kVp unenhanced CT for the assessment of hepatic steatosis in liver transplantation donors using magnetic resonance (MR) spectroscopy as a reference standard.
METHODS: This retrospective study included 165 potential donors (male:female =114:51, 36.5±12.0 years old) who underwent 100-kVp single-slice unenhanced CT scan and MR spectroscopy. The difference between hepatic and splenic attenuation (CTL-S) and liver-to-spleen attenuation ratio (CTL/S) were calculated. Reference standard was the fat signal fraction measured by MR spectroscopy. Limits of agreement between CT measurements and the reference standard were calculated. Areas under receiver operating characteristic curves (AUROCs) of CTL-S and CTL/S were compared for the diagnosis of moderate to severe steatosis. Cut-off values of CTL-S and CTL/S that provided a balance between sensitivity and specificity and the highest specificity using the lower limit of the reference range were calculated.
RESULTS: Eighty-seven subjects had a non-steatotic liver. Sixty-one subjects had mild steatosis and 17 subjects had moderate to severe steatosis based on MR spectroscopy. CTL-S and CTL/S values were negatively correlated with the fat signal fraction (P<0.001) and limits of agreement were -8.4% to 8.4% for CTL-S and -9.6% to 9.6% for CTL/S. AUROCs of CTL-S and CTL/S for diagnosing moderate to severe steatosis were 0.956 and 0.957, respectively. Cut-off values of CTL-S and CTL/S for diagnosis of moderate to severe steatosis by the Youden index were -0.5 HU for CTL-S and 0.99 for CTL/S. Reference ranges of non-steatotic liver were -6.90 to 31.40 HU for CTL-S and 0.89 to 1.77 for CTL/S. Using -6.9 HU for CTL-S and 0.89 for CTL/S as cut-off values, the sensitivity and specificity for diagnosing moderate to severe steatosis were 70.59% and 90.54% (CTL-S) and 76.47% and 90.54% (CTL/S), respectively.
CONCLUSIONS: Measurements from a low-kVp unenhanced CT scan were negatively correlated with the degree of hepatic steatosis. Low-kVp unenhanced CT is a robust technique with reduced radiation exposure for diagnosing moderate to severe hepatic steatosis. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Liver; computed tomography (CT); magnetic resonance spectroscopy (MRS); steatosis

Year:  2022        PMID: 35111629      PMCID: PMC8739110          DOI: 10.21037/qims-21-474

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  36 in total

Review 1.  Evaluation of living liver donors.

Authors:  Yaw-Sen Chen; Yu-Fan Cheng; Vanessa H De Villa; Chih-Chi Wang; Chih-Che Lin; Tung-Liang Huang; Bruno Jawan; Chao-Long Chen
Journal:  Transplantation       Date:  2003-02-15       Impact factor: 4.939

Review 2.  CT of the Abdomen with Reduced Tube Voltage in Adults: A Practical Approach.

Authors:  Adeel R Seyal; Atilla Arslanoglu; Samir F Abboud; Azize Sahin; Jeanne M Horowitz; Vahid Yaghmai
Journal:  Radiographics       Date:  2015-10-16       Impact factor: 5.333

Review 3.  Clinical evaluation of diagnostic tests.

Authors:  Susan Weinstein; Nancy A Obuchowski; Michael L Lieber
Journal:  AJR Am J Roentgenol       Date:  2005-01       Impact factor: 3.959

4.  Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease.

Authors:  Seung Soo Lee; Youngjoo Lee; Namkug Kim; Seong Who Kim; Jae Ho Byun; Seong Ho Park; Moon-Gyu Lee; Hyun Kwon Ha
Journal:  J Magn Reson Imaging       Date:  2011-06       Impact factor: 4.813

5.  Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis.

Authors:  Michael S Middleton; Elhamy R Heba; Catherine A Hooker; Mustafa R Bashir; Kathryn J Fowler; Kumar Sandrasegaran; Elizabeth M Brunt; David E Kleiner; Edward Doo; Mark L Van Natta; Joel E Lavine; Brent A Neuschwander-Tetri; Arun Sanyal; Rohit Loomba; Claude B Sirlin
Journal:  Gastroenterology       Date:  2017-06-15       Impact factor: 22.682

6.  Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis.

Authors:  Perry J Pickhardt; Seong Ho Park; Luke Hahn; Sung-Gyu Lee; Kyongtae T Bae; Eun Sil Yu
Journal:  Eur Radiol       Date:  2011-12-04       Impact factor: 5.315

Review 7.  Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials.

Authors:  Cyrielle Caussy; Scott B Reeder; Claude B Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

8.  Visceral adiposity and hepatic steatosis at abdominal CT: association with the metabolic syndrome.

Authors:  Perry J Pickhardt; Young Jee; Stacy D O'Connor; Alejandro Muñoz del Rio
Journal:  AJR Am J Roentgenol       Date:  2012-05       Impact factor: 3.959

9.  Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.

Authors:  Kento Imajo; Takaomi Kessoku; Yasushi Honda; Wataru Tomeno; Yuji Ogawa; Hironori Mawatari; Koji Fujita; Masato Yoneda; Masataka Taguri; Hideyuki Hyogo; Yoshio Sumida; Masafumi Ono; Yuichiro Eguchi; Tomio Inoue; Takeharu Yamanaka; Koichiro Wada; Satoru Saito; Atsushi Nakajima
Journal:  Gastroenterology       Date:  2015-12-08       Impact factor: 22.682

10.  Donor Safety in Adult-Adult Living Donor Liver Transplantation: A Single-Center Experience of 356 Cases.

Authors:  Haipeng Meng; Jiayin Yang; Lunan Yan
Journal:  Med Sci Monit       Date:  2016-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.